BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 16238792)

  • 1. The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis.
    Mitsuishi K; Nakamura T; Sakata Y; Yuyama N; Arima K; Sugita Y; Suto H; Izuhara K; Ogawa H
    Clin Exp Allergy; 2005 Oct; 35(10):1327-33. PubMed ID: 16238792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of combined measurements of squamous cell carcinoma antigens 1 and 2 in diagnosing atopic dermatitis.
    Ohta S; Shibata R; Nakao Y; Azuma Y; Taniguchi K; Arima K; Suzuki S; Shiraishi H; Iwasaka T; Izuhara K
    Ann Clin Biochem; 2012 May; 49(Pt 3):277-84. PubMed ID: 22402915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
    Neis MM; Peters B; Dreuw A; Wenzel J; Bieber T; Mauch C; Krieg T; Stanzel S; Heinrich PC; Merk HF; Bosio A; Baron JM; Hermanns HM
    J Allergy Clin Immunol; 2006 Oct; 118(4):930-7. PubMed ID: 17030248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma-related antigen in children with acute asthma.
    Nishi N; Miyazaki M; Tsuji K; Hitomi T; Muro E; Zaitsu M; Yamamoto S; Inada S; Kobayashi I; Ichimaru T; Izuhara K; Nagumo F; Yuyama N; Hamasaki Y
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):391-7. PubMed ID: 15801252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment of a diagnostic system for allergic diseases aiming at personalized medicine--establishment of a novel ELISA system for SCCA].
    Ohta S; Azuma Y; Shiraishi H; Noguchi Y; Izuhara K
    Rinsho Byori; 2008 Nov; 56(11):980-5. PubMed ID: 19086453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of squamous cell carcinoma antigens 1 and 2 reflect disease severity and clinical type of atopic dermatitis in adult patients.
    Okawa T; Yamaguchi Y; Kou K; Ono J; Azuma Y; Komitsu N; Inoue Y; Kohno M; Matsukura S; Kambara T; Ohta S; Izuhara K; Aihara M
    Allergol Int; 2018 Jan; 67(1):124-130. PubMed ID: 28734739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
    Ezzat MH; Sallam MA; Shaheen KY
    Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of serpin squamous cell carcinoma antigen 2 in human tumor tissues and cell lines: evidence of protection from tumor necrosis factor-mediated apoptosis.
    Takeda A; Kajiya A; Iwasawa A; Nakamura Y; Hibino T
    Biol Chem; 2002; 383(7-8):1231-6. PubMed ID: 12437110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
    Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
    Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression of human squamous cell carcinoma antigens 1 and 2 in human cell lines.
    Hamada K; Hanakawa Y; Hashimoto K; Iwamoto M; Kihana T; Hirose S; Nakamura M; Ito M
    Oncol Rep; 2001; 8(2):347-54. PubMed ID: 11182054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
    Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
    Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
    Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
    Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis.
    Morioka T; Yamanaka K; Mori H; Omoto Y; Tokime K; Kakeda M; Kurokawa I; Gabazza EC; Tsubura A; Yasutomi Y; Mizutani H
    Br J Dermatol; 2009 Jun; 160(6):1172-9. PubMed ID: 19416272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis.
    Katagiri K; Arakawa S; Hatano Y
    Arch Dermatol Res; 2007 Jan; 298(8):397-401. PubMed ID: 17021766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atopic dermatitis in young children is associated with impaired interleukin-10 and interferon-gamma responses to allergens, vaccines and colonizing skin and gut bacteria.
    Dunstan JA; Hale J; Breckler L; Lehmann H; Weston S; Richmond P; Prescott SL
    Clin Exp Allergy; 2005 Oct; 35(10):1309-17. PubMed ID: 16238790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor-alpha but not interferon-gamma is the main inducer of inducible protein-10 in skin fibroblasts from patients with atopic dermatitis.
    Villagomez MT; Bae SJ; Ogawa I; Takenaka M; Katayama I
    Br J Dermatol; 2004 May; 150(5):910-6. PubMed ID: 15149503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma.
    AntĂșnez C; Torres MJ; Mayorga C; Corzo JL; Jurado A; SantamarĂ­a-Babi LF; Vera A; Blanca M
    Pediatr Allergy Immunol; 2006 May; 17(3):166-74. PubMed ID: 16672002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables.
    Park JH; Choi YL; Namkung JH; Kim WS; Lee JH; Park HJ; Lee ES; Yang JM
    Br J Dermatol; 2006 Oct; 155(4):778-83. PubMed ID: 16965428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of novel biomarkers for Personalized medication for atopic dermatitis].
    Ohta S; Taniguchi K; Arima K; Suzuki S; Shiraishi H; Masuoka M; Izuhara K
    Rinsho Byori; 2013 Mar; 61(3):247-55. PubMed ID: 23785795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
    Chen L; Overbergh L; Mathieu C; Chan LS
    Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.